Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    biopure OR polyheme OR oxycyte OR hemolink OR stanate | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
2 Unknown  A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery
Condition: Coronary Artery Disease
Intervention: Drug: HBOC-201 (hemoglobin glutamer-250 bovine)
3 Unknown  A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
Condition: Wounds and Injuries
Interventions: Drug: Hemoglobin-based oxygen carrier-201 (HBOC 201);   Other: Standard of Care

Indicates status has not been verified in more than two years